The authors of the statement emphasise that, in light of the psychological, social, economic, civil society, and political problems caused by the coronavirus pandemic, curbing its spread must be given the highest priority.
Although the pandemic will continue to define economic and societal life for months to come, criteria and policies have to be developed that go beyond the acute limitation of fundamental rights such as the freedom of movement to ensure a gradual return to normality.
According to the statement, such a gradual relaxation of regulations requires consistently low infection rates to prevent the healthcare system from being overloaded, increasing identification of infected persons, and disciplined compliance with protective measures (hygiene, the wearing of mouth and nose protection, physical distancing).
The paper addresses questions of data- and model-based decision support and perspectives concerning the evaluation of legal rights. It also proposes recommendations for buffering psychological and social impacts.
Besides, measures for the economic and financial sector, as well as the area of education, are illustrated. The statement identifies the following principles as a general framework: the protection of every individual human being and the facilitation of a dignified life, as well as the gradual restoration of the citizens' social, economic, political, and cultural capacity for action. The concepts of sustainability and resilience should guide all measures.
The third statement supplements the two previous ad-hoc-statements on health policy issues in dealing with the pandemic issued on April 3 and March 21.
These recommendations continue to apply. In particular, the current focus on caring for COVID-19 patients must not lead to a shortfall in the care of others. Sufficient capacities in intensive care units and stocks of protective equipment should be held in reserve for new outbreaks of the pandemic.
The healthcare system should be analysed and adjusted accordingly. Furthermore, every effort has to be made to expedite the research into effective medications and the development of quickly and widely available vaccines. The German National Academy of Sciences Leopoldina will closely monitor and support this process.
New study reveals increased risk of allergic diseases after COVID-19 infection